Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06188208
Title A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vividion Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA | AUS

No variant requirements are available.